openPR Logo
Press release

Bioink Market is Set to Surge at 18.8% CAGR, to Reach US$ 1.03 Billion by 2034: Fact.MR Report

03-31-2025 09:33 AM CET | Health & Medicine

Press release from: Fact.MR

Bioink Market

Bioink Market

The size of the global bioink market is estimated at US$ 185.6 million in 2024, according to a new study released by Fact.MR. Global demand for bioinks is expected to grow at a prolific CAGR of 18.8% and reach a market value of US$ 1.03 billion through the end of 2034.

Continuous development in 3D printing technology is expected to drive growth in the sales of compatible bioinks in the future. Technology improvements facilitate the creation of more intricate, functional, and accurate organ and tissue printing, which requires manufacturing of specialized bioinks capable of replicating natural tissues.

For More Insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=9475

What is Driving Fast Global Bioink Market Growth?

"Rising Cases of Organ Failure Necessitating Production of 3D Printed Organs

Increased cases of organ failure due to various causes, such as accidents, burns, old age, and poor lifestyle, are expected to lead to growing demand for bioinks because of the increased demand for 3D-printed organs. The process of 3D printing is expected to assist in addressing the challenges of organ shortages worldwide. There is no real drug therapy available to reverse organ failure.

The Organ Procurement and Transplantation Network issued a report in 2021. According to the statistics presented via the report, around 180,000 patients suffer from renal failure every year and 6,000 renal transplants are conducted.

Country-wise Insights

North America is also predicted to have 56.9% market share in the world by 2034, according to the report by Fact.MR, a market research and competitive intelligence company. Growing adoption of 3D bioprinters and greater investments by firms to offer tissue-specific bioinks are expected to drive revenue streams in the future.

China is projected to hold a 46.6% share of the East Asian market in 2034. The Chinese government is actively striving to be self-reliant in the biopharma business. Enhancement of the Chinese biopharmaceutical business is one of the priority areas for the government in China. Apart from that, significant investments made by the government in biotech R&D exercises are projected to broaden opportunities for players.

Category-wise Insights

Worldwide demand for collagen-based bioinks is anticipated to grow immensely due to their improved compatibility and contribution towards the construction of fibrous networks for the human body. These trends in the bioink market are anticipated to create financially rewarding opportunities for players in the future.

The collagen segment is anticipated to capture 19% of the world market by 2034. Collagen is employed as one of the major structural elements of tendon, bone, skin, and other connective tissues. The facile compatibility of collagen coupled with its capacity to create a fibrous network in the human body is expected to drive its uptake.

Browse Full Report: https://www.factmr.com/report/bioink-market

Competitive Landscape

Leading producers of bioinks are supplying technologically superior products. Besides, mergers & acquisitions to expand offerings are undertaken by them. Moreover, quality control of products, supply chain management, and R&D are expected to assist these players in achieving a competitive advantage.

For example :

CollPlant introduced Collink.3DTM to use in the 3D bioprinting of human organs, scaffolds, and tissues during November 2021.
BICO bought Advanced BioMatris in August 2021. The latter is specialized in 3D research applications and is America-based with a robust portfolio of collagen bioinks, chemically modified proteins, and other cell assays.

Some major players in the bioink market include Merck KGaA, CELLINK, BICO, CollPlant Biotechnologies Ltd., Humabiologics, Allevi, Inc., Black Drop Biodrucker Gmb, Foldink, UPM Biomedicals, Axolotl Biosciences, Manchester BIOGEL, TheWell Bioscience Inc., and 3DPL.

Segmentation of Bioink Market Research

By Material:
Agarose
Alginate
Chitosan
Collagen
Fibrinogen
Gelatin
Hyaluronic Acid
Graphene
Hydroxyapatite
Cell- & Tissue-derived ECM
Poly (Ethylene Glycol) Diacrylate (PEGDA)
By Source:
Natural
Synthetic
By Printing Modality:
Extrusion-based Bioprinting
Inkjet-based Bioprinting
Laser-based Bioprinting
By Application:
Tissue Engineering & Regenerative Medicines
Tissue Transplantation
Pharmaceuticals & High-throughput Screening
By Organ:
Human Ears
Kidneys
Liver
Heart
Skin
Cartilages
Bones
Stem Cells
Blood Vessels
Cancer Research
Lungs
Muscles
By End User:
Medical Device Manufacturers
Pharmaceutical Companies
Research & Academic Institutions
Contract Research Organizations
By Region:
North America
Europe
East Asia
Latin America
Middle East & Africa
South Asia & Oceania

Check out More Related Studies Published by Fact.MR:

Postpartum Hemorrhage (PPH) Treatment Devices Market
https://www.factmr.com/report/postpartum-hemorrhage-pph-treatment-devices-market

Breast Imaging Technologies Market
https://www.factmr.com/report/breast-imaging-technologies-market

Venipuncture Procedure Market
https://www.factmr.com/report/venipuncture-procedure-market

Dental Mirrors Market
https://www.factmr.com/report/dental-mirrors-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Bioink Market is Set to Surge at 18.8% CAGR, to Reach US$ 1.03 Billion by 2034: Fact.MR Report here

News-ID: 3946988 • Views:

More Releases from Fact.MR

Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CAGR at a 5.3%
Fine Blanking Tools Market Projected to Reach USD 1.43 Billion by 2035 | U.S. CA …
The global Fine Blanking Tools Market is set for steady growth over the next decade, driven by rising demand for high-precision components, ongoing industrial automation, and surging requirements from automotive, electronics, and aerospace sectors. According to a recent forecast, the market is expected to grow from approximately USD 948.1 million in 2025 to USD 1,430.6 million by 2035, at a compound annual growth rate (CAGR) of about 4.2 % between
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; Others.
10-08-2025 | Health & Medicine
Fact.MR
Benzodiazepine Drugs Market is Expanding USD 5.4 billion by 2035 | Pfizer Inc.; …
The global benzodiazepine drugs market is projected to expand in the coming decade, driven by growing incidence of anxiety, insomnia, alcohol-withdrawal disorders, and advances in pharmaceutical formulations. According to a recent Fact.MR report, the market was valued at approximately USD 2.35 billion in 2022, and is expected to grow at a compound annual growth rate (CAGR) of 2.8% to reach USD 3.1 billion by 2032. Market Drivers & Outlook The demand for
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Advances in 2D, Cart-Based Systems & AI-Enabled Portability
10-08-2025 | Health & Medicine
Fact.MR
Ultrasound Systems Market to Surge to Nearly USD 20 Billion by 2035, Led by Adva …
The global Ultrasound Systems Market is on a strong growth trajectory, projected to rise from USD 10.8 billion in 2025 to approximately USD 19.7 billion by 2035, expanding at a CAGR of 6.2% during the forecast period. This growth is fueled by the rising demand for non-invasive diagnostic imaging, the increasing prevalence of chronic diseases, expanding healthcare infrastructure, and continuous technological innovations such as AI integration and portable imaging systems. Key
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethicon US LLC, Cardica Inc., Smith & Nephew Plc, CONMED Corporation., Purple Surgical Inc., Dextera Surgical Inc, and Others.
10-08-2025 | Health & Medicine
Fact.MR
Surgical Staplers Market Is Forecasted To Reach USD 6.0 Billion In 2025 | Ethico …
The global Surgical Staplers Market is forecast to show strong growth over the next decade, nearly doubling in value as demand surges for efficient, reliable wound closure in advanced surgical procedures. According to the latest Fact.MR Surgical Staplers Market Size & Share Forecast Outlook 2025-2035 report, the market is expected to grow from USD 6.0 billion in 2025 to USD 12.5 billion by 2035, at a compound annual growth rate

All 5 Releases


More Releases for Bioink

Bioink Market COVID-19 Impact Analysis, Business Strategies, Revenue and Growth …
The Bioink Market size was valued at USD 224.93 Mn. in 2024 and the total revenue is expected to grow by 20.48% from 2025 to 2032, reaching nearly USD 998.57 Mn.' Bioink Market Overview: The Bioink Market is witnessing remarkable growth driven by advancements in 3D bioprinting technology and the increasing demand for tissue engineering and regenerative medicine. Bioinks-composed of living cells and compatible biomaterials-are essential for creating complex biological structures
Bioink Market to Reach USD 4.3 Billion by 2034
Bioinks are a crucial component of 3D bioprinting, a cutting-edge technology that uses living cells, biomaterials, and bioactive molecules to print biological tissues, organs, and medical devices. Bioinks enable the creation of functional tissue models, personalized medicine, and tissue regeneration, and are playing a vital role in advancing regenerative medicine and organ transplantation. As 3D bioprinting technology evolves, bioinks are becoming increasingly sophisticated, with advancements in their properties, compatibility with
Bioink Market Demand, High Growth Rate to Reach USD 687.96 Mn. by 2030
The Bioink Market was valued at USD 186.70 million in 2023, with projections indicating substantial growth in the coming years. The market is expected to expand at a CAGR of 20.48% from 2024 to 2030, reaching an estimated revenue of nearly USD 687.96 million by the end of the forecast period. This rapid growth is driven by advancements in bioprinting technology, increasing applications in regenerative medicine, and rising demand for customized
Bioink Manufacturing Plant Project Report 2024: Setup Details, Capital Investmen …
IMARC Group's report, titled "Bioink Manufacturing Plant Project Report 2024: Industry Trends, Plant Setup, Machinery, Raw Materials, Investment Opportunities, Cost and Revenue" provides a complete roadmap for setting up a bioink manufacturing plant. The report covers various aspects, ranging from a broad market overview to intricate details like unit operations, raw material and utility requirements, infrastructure necessities, machinery requirements, manpower needs, packaging and transportation requirements, and more. In addition to the
Bioink Market Reach USD 687.96 Mn.: Growth Projections and Key Drivers
Anticipated Growth in Revenue: The Bioink Market size was valued at USD 186.70 Mn. in 2023 and the total revenue is expected to grow by 20.48% from 2024 to 2030, reaching nearly USD 687.96 Mn. Bioink Market Overview: The bioink system market is experiencing robust growth driven by advancements in 3D bioprinting technology and increasing applications in regenerative medicine and pharmaceutical research. Bioink systems play a crucial role in enabling the precise deposition
04-19-2024 | Health & Medicine
Fact.MR
Bioink Market Expected to Reach US$ 1.03 Billion by 2034 with 18.8% CAGR
In 2024, the global bioink market (バイオインク市場) is estimated at US$ 185.6 million. Forecasts project a remarkable Compound Annual Growth Rate (CAGR) of 18.8%, catapulting the demand for bioinks to reach a substantial market value of US$ 1.03 billion by 2034. Recent years have witnessed a consistent rise in the necessity for organ replacements and tissue regeneration. Innovations in these fields are anticipated to facilitate the transformation of damaged tissues into